百时美施贵宝：以价值价格买入增长组合 (NYSE:BMY)
· seekingalpha.com
百时美施贵宝的增长组合现在占收入的近60%，抵消了传统药物的下滑，支撑了总收入增长。了解为什么BMY股票值得买入。
iREIT+HOYA Capital is the premier income-focused investing service on Seeking Alpha. Our focus is on income-producing asset classes that offer the opportunity f...